The LKB1 tumour suppressor phosphorylates and activates AMPK (AMP-activated protein kinase) when cellular energy levels are low, thereby suppressing growth through multiple pathways, including inhibiting the mTORC1 (mammalian target of rapamycin complex 1) kinase that is activated in the majority of human cancers. Blood glucose-lowering Type 2 diabetes drugs also induce LKB1 to activate AMPK, indicating that these compounds could be used to suppress growth of tumour cells. In the present study, we investigated the importance of the LKB1–AMPK pathway in regulating tumorigenesis in mice resulting from deficiency of the PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumour suppressor, which drives cell growth through overactivation of the Akt and mTOR (mammalian target of rapamycin) kinases. We demonstrate that inhibition of AMPK resulting from a hypomorphic mutation that decreases LKB1 expression does not lead to tumorigenesis on its own, but markedly accelerates tumour development in PTEN+/− mice. In contrast, activating the AMPK pathway by administration of metformin, phenformin or A-769662 to PTEN+/− mice significantly delayed tumour onset. We demonstrate that LKB1 is required for activators of AMPK to inhibit mTORC1 signalling as well as cell growth in PTEN-deficient cells. Our findings highlight, using an animal model relevant to understanding human cancer, the vital role that the LKB1–AMPK pathway plays in suppressing tumorigenesis resulting from loss of the PTEN tumour suppressor. They also suggest that pharmacological inhibition of LKB1 and/or AMPK would be undesirable, at least for the treatment of cancers in which the mTORC1 pathway is activated. Most importantly, our results demonstrate the potential of AMPK activators, such as clinically approved metformin, as anticancer agents, which will suppress tumour development by triggering a physiological signalling pathway that potently inhibits cell growth.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
June 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
May 14 2008
Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice Available to Purchase
Xu Huang;
Xu Huang
1
*MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
1Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Stephan Wullschleger;
Stephan Wullschleger
*MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Search for other works by this author on:
Natalia Shpiro;
Natalia Shpiro
*MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Search for other works by this author on:
Victoria A. McGuire;
Victoria A. McGuire
†College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Search for other works by this author on:
Kei Sakamoto;
Kei Sakamoto
*MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Search for other works by this author on:
Yvonne L. Woods;
Yvonne L. Woods
‡Department of Molecular Pathology, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, U.K.
Search for other works by this author on:
Wendy Mcburnie;
Wendy Mcburnie
‡Department of Molecular Pathology, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, U.K.
Search for other works by this author on:
Stewart Fleming;
Stewart Fleming
‡Department of Molecular Pathology, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, U.K.
Search for other works by this author on:
Dario R. Alessi
Dario R. Alessi
1
*MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
1Correspondence may be addressed to either of these authors (email [email protected] or [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
March 13 2008
Revision Received:
April 01 2008
Accepted:
April 03 2008
Accepted Manuscript online:
April 03 2008
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2008 Biochemical Society
2008
Biochem J (2008) 412 (2): 211–221.
Article history
Received:
March 13 2008
Revision Received:
April 01 2008
Accepted:
April 03 2008
Accepted Manuscript online:
April 03 2008
Connected Content
This is a commentary on:
Cancer therapy: staying current with AMPK
Citation
Xu Huang, Stephan Wullschleger, Natalia Shpiro, Victoria A. McGuire, Kei Sakamoto, Yvonne L. Woods, Wendy Mcburnie, Stewart Fleming, Dario R. Alessi; Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem J 1 June 2008; 412 (2): 211–221. doi: https://doi.org/10.1042/BJ20080557
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |